Listings: Peter Kaffka's Eagles Nest House Is on the Market for Almost $3 Million USD
Summary
Nestled among the evergreens and perched above the inlet, Eagles Nest House is a striking example of West Coast modernism, designed in 1965 by architect Peter Kaffka. Kaffka, known for his belief that buildings should carry meaning across generations, crafted this cedar-and-brick residence to harmonize with its natural surroundings. The home was commissioned by one of the engineers behind the Burrard Street Bridge. Fragments of the bridge itself are embedded in the twin fireplaces, adding a unique historical touch.
The single-level residence offers 2,265 square feet of living space, designed to maximize simplicity without compromise. Large windows frame expansive views of Eagle Harbour, while the open layout enhances natural light and connectivity with the landscape. The home's three bedrooms and two bathrooms provide a comfortable yet refined living experience, complemented by thoughtful design elements that emphasize permanence and place. Kaffka's approach to architecture – blending functionality with artistic expression – remains evident throughout the property, making it a rare find for admirers of mid-century modern design.
Currently listed for $2,995,000 USD, Eagles Nest House stands as a testament toVancouver's architectural legacy. The property sits on an 18,500-square-foot lot, offering ample space and privacy within the Eagle Harbour community of West Vancouver. With its historical significance and meticulous craftsmanship, the home presents a unique opportunity for buyers seeking a piece of architectural history. For more information, visit the realtors'website.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hypebeast
4 days ago
- Hypebeast
Listings: Peter Kaffka's Eagles Nest House Is on the Market for Almost $3 Million USD
Summary Nestled among the evergreens and perched above the inlet, Eagles Nest House is a striking example of West Coast modernism, designed in 1965 by architect Peter Kaffka. Kaffka, known for his belief that buildings should carry meaning across generations, crafted this cedar-and-brick residence to harmonize with its natural surroundings. The home was commissioned by one of the engineers behind the Burrard Street Bridge. Fragments of the bridge itself are embedded in the twin fireplaces, adding a unique historical touch. The single-level residence offers 2,265 square feet of living space, designed to maximize simplicity without compromise. Large windows frame expansive views of Eagle Harbour, while the open layout enhances natural light and connectivity with the landscape. The home's three bedrooms and two bathrooms provide a comfortable yet refined living experience, complemented by thoughtful design elements that emphasize permanence and place. Kaffka's approach to architecture – blending functionality with artistic expression – remains evident throughout the property, making it a rare find for admirers of mid-century modern design. Currently listed for $2,995,000 USD, Eagles Nest House stands as a testament toVancouver's architectural legacy. The property sits on an 18,500-square-foot lot, offering ample space and privacy within the Eagle Harbour community of West Vancouver. With its historical significance and meticulous craftsmanship, the home presents a unique opportunity for buyers seeking a piece of architectural history. For more information, visit the realtors'website.
Yahoo
04-06-2025
- Yahoo
Canadian Multiple Sclerosis Nurses Among Winners of International Nightingale Award 2025
Four Canadian nurses are among eleven global recipients of the International Nightingale award for excellence in MS nursing. The awards are presented by the International Organization of Multiple Sclerosis Nurses (IOMSN) with support from Merck KGaA, Darmstadt, Germany. MISSISSAUGA, ON, June 4, 2025 /CNW/ - EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, is pleased to announce four Canadian nurses are among the recipients of the International Organization of Multiple Sclerosis Nurses (IOMSN) 2025 International Nightingale Award. The International Nightingale Award was launched in 2020 by IOMSN, with support from Merck KGaA, Darmstadt, Germany in celebration of the International Year of the Nurse and Midwife. "As a company dedicated to advancing multiple sclerosis care for over 25 years, we recognize that MS nurses play a vital role in providing care and support to patients. We are excited to collaborate with the IOMSN in this initiative, which celebrates nursing professionals and supports impactful projects that enhance patient outcomes," said Javed Alam, Managing Director of EMD Serono Canada. Having Canadian recipients of the International Nightingale Award recognizes the significance of MS nurse contributions to patient management and highlights the leadership role that Canadian nurses play on a global level. Shantha George, a community MS nurse practitioner in Edmonton, will receive $5,000 USD to support her Fight Back: Living Well with MS Program, an initiative that focuses on lifestyle management for mental health where patients learn tips to manage anxiety and depression including breathing techniques, drumming and yoga. Stephanie McLeod, a nurse practitioner at the Alberta Neurologic Centre in Calgary will receive $5,000 USD to support the development of a new program to enhance patient and family education, empowering those affected with MS with the knowledge and support they need. Lou-Anne Robertson, a registered nurse at the Central Alberta Multiple Sclerosis Clinic in Red Deer will receive $5,000 USD to support her efforts to raise awareness about the benefits of MS nurse certification for patient care and professional growth. Trudy Campbell, a nurse practitioner at the Halifax MS Clinic, Nova Scotia Health will receive $5,000 USD to support her work on evidence informed, holistic care pathways related to health promotion to support healthy aging for persons with MS. "Since 2020, IOMSN, EMD Serono and Merck KGaA Darmstadt, Germany have proudly celebrated 'The Lady with the Lamp', Florence Nightingale, who is a symbol of compassion, data-driven care, and nursing excellence. The IOMSN Nightingale Awards empower nurses to bring bold ideas to life, driving meaningful change for those living with MS" said Bonnie Blain, President of the IOMSN. " These awards not only recognize achievement but also inspire continued innovation and leadership in nursing. We are thrilled to partner again with Merck KGaA Darmstadt, Germany to present the 2025 International Nightingale Awards. I am honored to celebrate these Canadian Nightingale Recipients whose impactful work has the potential to improve the lives of their patients and resonate across their communities." The International Nightingale Award was awarded to eleven eligible candidates who live and work in countries outside of the United States. Each will receive funding of up to 5000 US Dollars for current projects that require ongoing and/or additional funding for the growth of the program; proposed time-limited projects; personal activities that will support the professional growth and development of an MS nursing professional; and/or nursing research in MS or a related field. About Multiple SclerosisMultiple Sclerosis (MS) is a degenerative autoimmune disease in which the myelin sheath around the nerves in the brain and spinal cord are inflamed and often damaged. It is estimated that approximately 2.3 million people have MS worldwide. Canada has one of the highest rates of MS in the world with one in 385 people living with the disease. While symptoms vary, the most common symptoms of MS include extreme fatigue, lack of coordination, weakness, tingling, impaired sensation, vision problems, bladder problems, cognitive impairment and mood changes. The relapsing forms of MS are the most common type at the time of diagnosis. About the International Organization of Multiple Sclerosis Nurses (IOMSN)Founded on May 30, 1997, International Organization of Multiple Sclerosis Nurses (IOMSN) is the first and only international organization focusing solely on the needs and goals of professional nurses, anywhere in the world, who care for people with multiple sclerosis. Mentoring, educating, networking, sharing - the IOMSN supports nurses in their continuing effort to offer hope. The mission of the IOMSN is the establishment and perpetuation of a specialized branch of nursing in multiple sclerosis; to establish standards of nursing care in multiple sclerosis; to support multiple sclerosis nursing research; and to educate the health care community about multiple sclerosis; and to disseminate this knowledge throughout the world. The ultimate goal of the IOMSN is to improve the lives of all those persons affected by multiple sclerosis through the provision of appropriate healthcare services and to make hope happen! About EMD Serono, CanadaEMD Serono, Canada, is the Canadian biopharmaceutical business of Merck KGaA, Darmstadt, Germany. EMD Serono, Canada has integrated cutting-edge science, innovative products and devices, and industry-leading patient support and access programs. EMD Serono, Canada has deep expertise in neurology, fertility and endocrinology, as well as a robust pipeline of potential therapies in neurology, oncology, immunology and immuno-oncology. Today, EMD Serono, Canada has more than 100 employees across Canada with headquarters in Mississauga, Merck KGaA, Darmstadt, GermanyMerck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 56,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2018, Merck KGaA, Darmstadt, Germany, generated sales of € 14.8 billion in 66 company holds the global rights to the name and trademark "Merck" internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company's technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. SOURCE EMD Serono Canada View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
04-06-2025
- Yahoo
Defiance Silver Signs Long-Term Access Agreement at Tepal
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2025) - Defiance Silver Corp. (TSXV: DEF) (FSE: D4E) (WKN: A1JQW5) ("Defiance" or the "Company") is pleased to announce that through its subsidiary, Geologix Mexico S.A. de C.V., it has successfully secured a long-term surface access agreement (the "Agreement") for its 100%-owned Tepal Gold-Copper Project, located in Michoacán, Mexico. Surface Rights Agreement HighlightsUnder the terms of the six-year agreement, the Company has secured the right to conduct surface exploration, drilling, and engineering studies at the Tepal Gold-Copper project. Chris Wright, Executive Chairman & CEO of Defiance Silver, commented: "Securing long-term surface access to the Tepal Project represents a key milestone event for Defiance. This is the first formal agreement with the surface landowner, and it provides the certainty we need to advance our exploration and development work, such as: detailed mapping, sampling, and drilling across the North, South, and Tizate zones, while also evaluating new targets within the broader project area." Restructured Option to Acquire Royalty at the Tepal ProjectDefiance is pleased to announce that it has successfully restructured the option agreement (See News Release dated January 16th, 2023) to acquire the 2.5% Net Smelter Return (NSR) royalty associated with its Tepal Gold-Copper project with the project vendor, Minera Tepal S.A. de C.V. The revised payment schedule for the NSR option agreement is USD$75,000/month starting July 1, 2025 through February 1, 2026, and then USD $150,000/month from July 1, 2026 through September 1, 2027. Extension of San Acacio Option PaymentAdditionally, the Company has secured an extension for the final payment of the option agreement on the San Acacio land package at its Zacatecas Silver-Polymetallic project. Defiance through its wholly owned subsidiary, Minera Santa Remy S.A., has, at the Vendor's request, agreed to extend the term of its option to acquire 100% of the San Acacio property in the Zacatecas district. As a result of this amendment, the scheduled payment due March 31, 2025, has now been changed to June 30, 2026 (See October 31st and December 20th, 2024 news for more details). The amendment was signed by both parties and is pending ratification in the presence of a notary public in Mexico City. There were no changes to the economic terms of the option agreement. On behalf of Defiance Silver Corp."Chris Wright"Chairman and CEO For more information, please contact: Investor RelationsTel: +1 (604) 343-4677info@ Suite 2900-550 Burrard StreetVancouver, BCCanadaV6C 0A3 Disclaimer Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Cautionary Statements Regarding Forward-Looking Information Information contained in this news release which are not statements of historical facts may be "forward-looking information" for the purposes of Canadian securities laws. Such forward-looking information involves risks, uncertainties and other factors that could cause actual results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward looking information. Forward-looking statements are generally identifiable by use of the words "believe", "expect", "anticipate", "contemplate", "plan", "intend", "continue", "budget", "estimate", "may", "will", "schedule", "understand" or the negative of these words or other variations on these words or comparable terminology. These forward-looking statements relate to, among other things: the Company's ability to complete certain payments in relation to its Tepal and Zacatecas projects. Forward-looking information is necessarily based upon a number of estimates and assumptions that, while considered reasonable by Defiance, are inherently subject to significant technical, political, business, economic and competitive uncertainties and contingencies, which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Known and unknown factors could cause actual results to differ materially from those projected in the forward-looking information. Factors and assumptions that could cause actual results or events to differ materially from current expectations include, among other things and without limitation: political risks associated with the Company's operations in Mexico; the inability of the Company and its subsidiaries to enforce their legal rights in certain circumstances; failure to establish estimated mineral resources; the possibility that future exploration results will not be consistent with the Company's expectations; and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities. For additional risk factors, please see the Company's most recently filed Management Discussions & Analysis for its financial year ended June 30, 2024 available on SEDAR+ at There can be no assurances that forward-looking information and statements will prove to be accurate, as many factors and future events, both known, and unknown could cause actual results, performance or achievements to vary or differ materially from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements contained herein or incorporated by reference. Accordingly, all such factors should be considered carefully when making decisions with respect to Defiance, and prospective investors should not place undue reliance on forward looking information. Forward-looking information in this news release is made as at the date hereof. The Company assumes no obligation to update or revise forward-looking information to reflect changes in assumptions, changes in circumstances or any other events affecting such forward-looking information, except as required by applicable law. About Defiance Silver Corp. Defiance Silver Corp. (TSXV: DEF) (OTCQX: DNCVF) (FSE: D4E) is an exploration and development company advancing the district-scale Zacatecas project, located in the historic Zacatecas Silver District and the Tepal Gold/Copper Project in Michoacán state, Mexico. Defiance is managed by a team of proven mine developers with a track record of exploring, advancing, and developing several operating mines and advanced resource projects. Defiance's corporate mandate is to advance its projects through capital-efficient exploration, focused on resource growth and new mineral discoveries. To view the source version of this press release, please visit
